New sleep drug shows promise in Real-World study
NCT ID NCT06311864
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 90 Canadian adults with insomnia who were prescribed daridorexant. Researchers tracked changes in quality of life, work productivity, and sleep symptoms over three months using questionnaires. The goal was to see how the medication helps people in everyday life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PROxy Network, an initiative of PeriPharm inc.
Montreal, Quebec, H2Y 2H4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light therapy during sleep may offer a Drug-Free path to better rest
- Mind over bladder: can sleep training curb nighttime urges?
- Can an ancient herbal formula unlock better sleep and weight loss?
- Could a simple sleep guide ease insomnia in lung disease?
- Digital sleep coaching for seniors: a new hope for insomnia?
- Fixing sleep, fortifying hearts: a new trial tests the link